[1]左 娟,刘 洁,朱 瑾,等.无创基因检测(NIPT)对胎儿染色体异常筛查的临床应用[J].现代检验医学杂志,2018,33(05):15-18.[doi:10.3969/j.issn.1671-7414.2018.05.005]
　ZUO Juan,LIU Jie,ZHU Jin,et al.Application of Noninvasive Prenatal Testing in the Screening of Chromosome Abnormality[J].Journal of Modern Laboratory Medicine,2018,33(05):15-18.[doi:10.3969/j.issn.1671-7414.2018.05.005]
点击复制

无创基因检测(NIPT)对胎儿染色体异常筛查的临床应用()
分享到：

《现代检验医学杂志》[ISSN:/CN:]

卷:
第33卷
期数:
2018年05期
页码:
15-18
栏目:
论著
出版日期:
2018-11-18

文章信息/Info

Title:
Application of Noninvasive Prenatal Testing in the Screening of Chromosome Abnormality
文章编号:
1671-7414(2018)05-015-04
作者:
左 娟; 刘 洁; 朱 瑾; 江玲玲; 黄建成; 李朝晖
福建医科大学附属闽东医院检验科,福建宁德 355000
Author(s):
ZUO Juan; LIU Jie; ZHU Jin; JIANG Ling-ling; HUANG Jian-cheng; LI Zhao-hui
Department of Laboratory Medicine,Mindong Hospital Affiliated to Fujian Medical University,Fujian Ningde 355000,China
关键词:
无创产前基因检测;  羊水;  染色体;  唐氏筛查
分类号:
R394-33
DOI:
10.3969/j.issn.1671-7414.2018.05.005
文献标志码:
A
摘要:
目的 探讨无创产前基因检测(NIPT)在预测胎儿染色体异常中的临床应用价值。方法 选取2016年4月～2018年4月在福建省宁德市闽东医院行NIPT的单活胎孕妇6 357例,按孕周分为早、中、晚孕期组,按孕龄分为高、低龄组,低龄组又按申请理由分唐氏筛查高风险组、临界风险组、单项指标或中位数倍数(MOM值)异常组,B超软指标异常组和直接选择NIPT组,对于结果异常者签署知情同意书行羊膜腔穿刺术。结果 ①6 357例孕妇共检出染色体异常76例,早、中、晚孕期组阳性率分别为2.17%,1.23%和0.70%,三者之间差异无统计学意义(χ2=2.265～6.052,均P>0.05); ②6 357例孕妇按孕龄和申请理由分组,各组阳性率分别为1.45%,1.07%,0.97%,0.60%,1.29%和1.15%,各组之间差异无统计学意义(χ2=0.017～1.809,均P>0.05); ③76例NIPT结果异常孕妇有64例接受了羊膜腔穿刺羊水细胞染色体检查,其中21,18和13-三体的诊断率分别为90%,100%和100%,符合率分别为88.9%,88.9%和50%; 性染色体的诊断率为83.9%,符合率61.5%; 其它染色体异常诊断率为58.3%,符合率为0。结论 ①不同孕期NIPT的阳性率之间无差异,孕妇可以尽早行NIPT,为后续介入性诊断争取时间; ②不同申请理由NIPT的阳性率之间无差异,高龄和错过唐筛时间的孕妇可将NIPT作为筛查胎儿染色体异常的首选,而唐筛高风险、临界风险、单项指标或MOM值异常的孕妇可将NIPT作为二线筛查,从而避免不必要的羊膜腔穿刺; ③NIPT不仅对21和18-三体具有较高的特异度和敏感度,对13-三体、性染色体也有一定的预示作用,可作为产前检测胎儿染色体异常的辅助手段。
Abstract:
Objective To explore the clinical applicationvalue of noninvasive prenatal testing(NIPT)in the screening of chromosome abnormality.Methods From April 2016 to April 2018,a total of6 357 cases of single pregnant women undergoing NIPT in Mindong Hospital were selected.They were divided into early-pregnancy group,mid-pregnancy group andlater-pregnancy group by gestational age.They also were divided into advancedmaternal age group and non-advanced maternal age group.The non-advanced maternal age group was secondly divided into high risk group,critical risk group,single index or MOM anomaly group about Down's syndrome screening,soft indexesanomaly group about ultrasonic diagnosis and preferred alternative group by reasons for application of NIPT.The pregnant women with high-risk NIPT results were suggested amniotic fluid puncture for karyotype analysis.Results①76 pregnant women were found with high-risk NIPT results.The positive rate was 2.17% in early-pregnancy group,1.23% in mid-pregnancy group and 0.70% in later-pregnancy group.They didn't have statistic significance(χ2=2.265～6.052,P>0.05).②A total of 6 537 cases were divided by ageand reason for application of NIPT.The positive rate were 1.45%,0.97%,0.60%,1.29% and 1.15% respectively.They didn't have statistic significance(χ2=0.017～1.809,P>0.05).③Among 76 pregnant women with high-risk NIPTresults,64 cases underwent amniotic fluid puncture for karyotype analysis.Thediagnosis rate of T21,T18 and T13 were 90%,100% and 100% respectively.The positive predictive values of T21,T18 and T13 were 88.9%,88.9% and 50%,respectively.The diagnosis rate of sex chromosome abnormality was 83.9%,the coincidence rate was 61.5%,the diagnosis rate of other chromosome abnormality was 58.3%,the coincidence rate was 0。Conclusion ①The positive rates didn't have significant difference among different pregnancy duration,so pregnant woman after 12 weeks can do NIPT as early as possible for strivingmore time for subsequent interventional diagnosis.②The positive rates didn'thave significant difference among different groups divided by reasons for application of NIPT,so pregnant women with advanced age or missing Down's syndromescreening can do NIPT as the first chioce for screening fetal chromosomal abnormality.The pregnant women with high risk,critical risk and single in dex or MOM anomaly in Down's syndrome screening select NIPT as second-line screening to avoiding unnecessary puncture.③NIPT not only have high specificity and sensitivity in screening of T21 and T18,but also have certain indicative for T13 and sex chromosome abnormality.NIPT can be a powerful and reliable supplementarymeans in screening fetal chromosomal abnormality.

参考文献/References:

[1] Lo YM,Corbetta N,Chamberlain PF,et al.Presence of fetal DNA in maternal plasma and serum[J].Lancet,1997,350(9076):485-487.
[2] Wilson RD.Committee Opinion No.640:Cell-Free D-NA Screening For Fetal Aneuploidy[C].Obstet Gynecol,2015,126(3):e31-e37.
[3] 殷一旋,梅 瑾,王 昊.无创产前基因检测及羊水产前诊断在高龄孕妇中的对照研究分析[J].中国优生与遗传杂志,2017,25(3):23-24,6.
Yin YX,Mei J,Wang H.The contrist study for amniotic fluid prenatal diagnosis and non-invastive gene detection in advanced maternal age[J].Chinese Journal of Birth Health and Heredity,2017,25(3):23-24,6.
[4] Gil MM,Revello R,Poon LC,et al.Clinical implementation of routine screening for fetal trisomies in the UK NHS:cell-free DNA test contingent on result from first-trimester combined test[C].Ultrasound Obstet Gynecol,2016,47(1):45-52.
[5] 李玉芝,任景慧,林琳华,等.大规模并行基因组测序技术应用于无创产前诊断染色体非整倍体的研究[J].华中科技大学报(医学版),2012,41(4):475-480.
Li YZ,Ren JH,Lin LH,et al.Non-invasive prenatal diagnosis of chromosome aneuploidy by massively parallel genomic sequencing technology[J].Acta Med Univ Sci Technol Huazhong(Medical Sciences),2012,41(4):475-480.
[6] Porreco RP,Garite TJ,Maurel K,et al.Noninvasive prenatal screening for fetal trisomies 21,18,13 and the common sex chromosome aneuploidies from maternal blood using massively parallel genomic sequencing of DNA[J].Am J ObstetGynecol,2014,211(4):e1-12.

备注/Memo

备注/Memo:
基金项目:福建省青年科研课题(2014-1-97)。
作者简介:左 娟(1981-),女,硕士研究生,主管技师,主要从事细胞遗传学研究,E-mail:zhiqing923@126.com。
通讯作者:李朝晖(1970-),男,主任技师,E-mail:li6336@163.com。
更新日期/Last Update: 2018-09-30